Accueil / Nouvelles et Évènements
Points saillants de la recherche
Glycoengineering provides insight into new cancer immunotherapies
By remodelling sugars on cell surfaces, GlycoNet researchers aim to map the linkages between proteins in the immune system and sugars on cancer cells
Redefining compatibility in organ transplantation
Applying a glycomics lens to the problem of organ donor-recipient compatibility, GlycoNet researcher Dr. Lori West is advancing the field of organ transplantation.
The secret to healthy aging
It’s all about monitoring sugar – but not in the way you may think
More stories
- Tout
- Prix
- Communauté
- Profil du Réseau
- Communiqué de presse
- Points saillants de la recherche
Top 10 stories from GlycoNet in 2022
A spotlight on some of the most exciting glycomics innovations from the past year.
Op-ed: Glycomics research supports a cure for Type 2 diabetes from plants
GlycoNet scientists at UBC have found a plant compound that helps control blood sugar levels in people with Type 2 diabetes.
Carbohydrate research in animal health supports Canadian economy
GlycoNet scientist Mariela Segura is developing glycomics-based solutions to improve livestock health.
GlycoNet start-up GlyCa Biosciences Inc. and Huron Innovation Inc. partner to improve prostate cancer detection
This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.
BioLab Business Magazine profile: GlycoNet facilitating glycomics research collaboration and innovation
A network serving the field of glycomics research provides a platform for connections and funding
A new research chair for dementia-causing diseases in children
Thanks to a large donation and the work of GlycoNet researcher and UdeM biochemist Alexey Pshezhetsky, the Elisa Linton Research Chair in Lysosomal Diseases will help treat Sanfilippo disease and similar genetic syndromes.
GlycoNet and Partners Invest $6.5 Million in Carbohydrate Research with One Health Focus
This investment will support state-of-the-art glycomics research that focuses on different aspects of One Health—human, animal and environmental health.
GlycoNet welcomes three new members to the Board of Directors
Janice Bailey, Jason Acker and Louise St-Onge have joined the GlycoNet Board of Directors
Tiny antibodies could help treat an aggressive type of breast cancer
GlycoNet researchers have developed specialized nanobodies that could enable the immune system to fight triple-negative breast cancer more effectively.
Réseau Canadien de la Glycomique
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tél.: 780-492-6204
Téléc.: 780-492-4147
Subscribe to GlycoNet’s Newsletter
© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.
French 
English